Indian Journal of Clinical and Experimental Ophthalmology
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Short Communication
Author Details :
Volume : 1, Issue : 2, Year : 2015
Article Page : 110-117
Abstract
Centuries of research on Glaucoma have not been able to add any factor to ‘Intraocular Pressure (IOP)’ the modification of which can halt the progression of this blinding disease. Therefore, the need for accurate IOP measurement has always been the interest of researchers and industry. An array of instruments has, thus, been developed, each surpassing the errors of the previous modalities. Although all of them have certain advantages, they have their limitations too. The present article puts light on the various developments in the field of tonometry over two centuries starting digital tonometry to the latest developments. It has also briefly touched the factors affecting intraocular pressure and its measurement.
How to cite : Singh M D, Chawla H, TONOMETRY- A JOURNEY OF TWO CENTURIES. Indian J Clin Exp Ophthalmol 2015;1(2):110-117
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
